Rapid proliferation due to better metabolic adaptation results in full virulence of a filament-deficient Candida albicans strain.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
23 06 2021
Historique:
received: 19 06 2020
accepted: 28 05 2021
entrez: 24 6 2021
pubmed: 25 6 2021
medline: 20 7 2021
Statut: epublish

Résumé

The ability of the fungal pathogen Candida albicans to undergo a yeast-to-hypha transition is believed to be a key virulence factor, as filaments mediate tissue damage. Here, we show that virulence is not necessarily reduced in filament-deficient strains, and the results depend on the infection model used. We generate a filament-deficient strain by deletion or repression of EED1 (known to be required for maintenance of hyphal growth). Consistent with previous studies, the strain is attenuated in damaging epithelial cells and macrophages in vitro and in a mouse model of intraperitoneal infection. However, in a mouse model of systemic infection, the strain is as virulent as the wild type when mice are challenged with intermediate infectious doses, and even more virulent when using low infectious doses. Retained virulence is associated with rapid yeast proliferation, likely the result of metabolic adaptation and improved fitness, leading to high organ fungal loads. Analyses of cytokine responses in vitro and in vivo, as well as systemic infections in immunosuppressed mice, suggest that differences in immunopathology contribute to some extent to retained virulence of the filament-deficient mutant. Our findings challenge the long-standing hypothesis that hyphae are essential for pathogenesis of systemic candidiasis by C. albicans.

Identifiants

pubmed: 34162849
doi: 10.1038/s41467-021-24095-8
pii: 10.1038/s41467-021-24095-8
pmc: PMC8222383
doi:

Substances chimiques

Cytokines 0
Fungal Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3899

Subventions

Organisme : NIDCR NIH HHS
ID : R00 DE026856
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

FEMS Yeast Res. 2015 Sep;15(6):
pubmed: 26205243
PLoS Pathog. 2017 Feb 9;13(2):e1006144
pubmed: 28182769
PLoS One. 2009;4(4):e5039
pubmed: 19352427
PLoS One. 2016 Mar 18;11(3):e0150001
pubmed: 26990086
Clin Infect Dis. 2009 Jun 15;48(12):1695-703
pubmed: 19441981
PLoS One. 2011 Apr 07;6(4):e18394
pubmed: 21512583
Infect Immun. 1994 Apr;62(4):1199-206
pubmed: 8132326
PLoS Pathog. 2016 Apr 13;12(4):e1005566
pubmed: 27073846
mBio. 2020 Aug 18;11(4):
pubmed: 32817109
Antimicrob Agents Chemother. 2001 Dec;45(12):3474-81
pubmed: 11709327
Mycoses. 2005 May;48(3):151-61
pubmed: 15842329
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Curr Opin Microbiol. 2015 Oct;27:10-7
pubmed: 26048423
Infect Immun. 2008 Jan;76(1):97-102
pubmed: 17967861
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
Eukaryot Cell. 2004 Oct;3(5):1076-87
pubmed: 15470236
Cell Host Microbe. 2019 Mar 13;25(3):432-443.e6
pubmed: 30870623
J Innate Immun. 2009;1(3):181-93
pubmed: 20375576
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Infect Dis. 2019 Sep 26;220(9):1477-1488
pubmed: 31401652
Cell Microbiol. 2004 Oct;6(10):915-26
pubmed: 15339267
Mol Biol Cell. 2008 Apr;19(4):1354-65
pubmed: 18216277
EMBO J. 2001 Sep 3;20(17):4753-61
pubmed: 11532939
Infect Immun. 2000 Dec;68(12):6712-9
pubmed: 11083786
FEMS Yeast Res. 2016 Mar;16(2):fow011
pubmed: 26851404
Eukaryot Cell. 2011 Jan;10(1):98-109
pubmed: 21097664
Microbiology (Reading). 2000 Aug;146 ( Pt 8):1881-1889
pubmed: 10931892
Cold Spring Harb Perspect Med. 2014 Nov 10;5(8):a019794
pubmed: 25384771
Acta Biochim Biophys Sin (Shanghai). 2015 May;47(5):335-41
pubmed: 25757952
Eukaryot Cell. 2009 Nov;8(11):1780-91
pubmed: 19734367
PLoS Pathog. 2009 Oct;5(10):e1000612
pubmed: 19816560
Am J Physiol. 1983 Mar;244(3):F223-34
pubmed: 6338740
Trends Microbiol. 2013 Jul;21(7):334-41
pubmed: 23685069
EMBO J. 2001 Sep 3;20(17):4742-52
pubmed: 11532938
J Fungi (Basel). 2018 Jan 11;4(1):
pubmed: 29371503
Eukaryot Cell. 2003 Oct;2(5):1053-60
pubmed: 14555488
Infect Immun. 1997 Nov;65(11):4468-75
pubmed: 9353021
J Infect Dis. 2005 Jul 15;192(2):336-43
pubmed: 15962230
Cell. 1997 Sep 5;90(5):939-49
pubmed: 9298905
mBio. 2016 Nov 22;7(6):
pubmed: 27879329
Nucleic Acids Res. 2017 Jan 4;45(D1):D592-D596
pubmed: 27738138
Microbiology (Reading). 2000 Aug;146 ( Pt 8):1763-1774
pubmed: 10931884
Future Microbiol. 2018 Jun 1;13:857-867
pubmed: 29877100
J Hosp Infect. 2009 May;72(1):9-16
pubmed: 19303662
Front Immunol. 2017 Jun 07;8:629
pubmed: 28638380
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Cell Microbiol. 2002 Mar;4(3):127-37
pubmed: 11906450
J Infect Dis. 1997 May;175(5):1169-75
pubmed: 9129081
Infect Immun. 2010 Apr;78(4):1650-8
pubmed: 20123707
Eukaryot Cell. 2011 Sep;10(9):1173-82
pubmed: 21764907
PLoS Biol. 2014 Apr 01;12(4):e1001830
pubmed: 24691005
J Innate Immun. 2013;5(6):581-90
pubmed: 23571837
Infect Immun. 2002 Jul;70(7):3689-700
pubmed: 12065511
J Innate Immun. 2011;3(2):180-99
pubmed: 21063074
Mol Immunol. 2009 Dec;47(2-3):465-75
pubmed: 19880183
EMBO J. 2004 Apr 21;23(8):1845-56
pubmed: 15071502
Med Mycol. 2007 Jun;45(4):321-46
pubmed: 17510856
Clin Vaccine Immunol. 2009 Mar;16(3):430-2
pubmed: 19144791
Eukaryot Cell. 2009 Apr;8(4):627-39
pubmed: 19252121
J Microbiol. 2011 Apr;49(2):171-7
pubmed: 21538235
Cell Microbiol. 2007 Dec;9(12):2938-54
pubmed: 17645752
Cold Spring Harb Perspect Med. 2014 Sep 04;4(12):a019695
pubmed: 25190251
Cell Microbiol. 2015 Apr;17(4):445-50
pubmed: 25346172
PLoS One. 2011 Feb 23;6(2):e17046
pubmed: 21407800
PLoS Pathog. 2018 Sep 25;14(9):e1007316
pubmed: 30252918
Mol Gen Genet. 1984;198(2):179-82
pubmed: 6394964
Nat Microbiol. 2016 Dec 12;2:16238
pubmed: 27941860
Toxicol Sci. 2013 Jan;131(1):13-25
pubmed: 23019274
mBio. 2018 Jun 5;9(3):
pubmed: 29871918
Eukaryot Cell. 2010 Feb;9(2):251-65
pubmed: 20023067
Pediatr Surg Int. 2012 Mar;28(3):299-303
pubmed: 22159634
PLoS Pathog. 2017 Oct 25;13(10):e1006699
pubmed: 29069103
Cell Microbiol. 2016 Feb;18(2):195-210
pubmed: 26242223
mBio. 2012 Dec 11;3(6):
pubmed: 23232717
Ther Clin Risk Manag. 2014 Feb 13;10:95-105
pubmed: 24611015
Gene. 2004 Oct 27;341:119-27
pubmed: 15474295
mSphere. 2020 Mar 11;5(2):
pubmed: 32161147
J Belg Soc Radiol. 2016 Dec 20;100(1):113
pubmed: 30151501
PLoS Pathog. 2008 Feb 8;4(2):e35
pubmed: 18282097
Cell Mol Life Sci. 2016 Nov;73(22):4265-4278
pubmed: 27312239
Nat Genet. 2010 Jul;42(7):590-8
pubmed: 20543849
Mol Microbiol. 2017 Feb;103(4):595-617
pubmed: 27623739
Trends Microbiol. 2014 Nov;22(11):614-22
pubmed: 25088819
Genetics. 2000 Sep;156(1):31-44
pubmed: 10978273
Eukaryot Cell. 2012 Feb;11(2):98-108
pubmed: 22158711
Anesthesiology. 2010 Apr;112(4):998-1004
pubmed: 20216399
Clin Infect Dis. 2001 Dec 15;33(12):1959-67
pubmed: 11702290

Auteurs

Christine Dunker (C)

Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Beutenbergstraße 11a, Jena, Germany.

Melanie Polke (M)

Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Beutenbergstraße 11a, Jena, Germany.
Laboratory Dr. Wisplinghoff, Department of Molecular Biology, Horbeller Strasse 18-20, Cologne, Germany.

Bianca Schulze-Richter (B)

Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Beutenbergstraße 11a, Jena, Germany.
Institute of Immunology, Molecular Pathogenesis, Center for Biotechnology and Biomedicine (BBZ), College of Veterinary Medicine, Leipzig University, Deutscher Platz 5, Leipzig, Germany.

Katja Schubert (K)

Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Beutenbergstraße 11a, Jena, Germany.

Sven Rudolphi (S)

Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Beutenbergstraße 11a, Jena, Germany.

A Elisabeth Gressler (AE)

Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Beutenbergstraße 11a, Jena, Germany.
Institute of Immunology, Molecular Pathogenesis, Center for Biotechnology and Biomedicine (BBZ), College of Veterinary Medicine, Leipzig University, Deutscher Platz 5, Leipzig, Germany.

Tony Pawlik (T)

Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Beutenbergstraße 11a, Jena, Germany.

Juan P Prada Salcedo (JP)

Department of Bioinformatics, Biocenter, Am Hubland, University of Würzburg, Würzburg, Germany.

M Joanna Niemiec (MJ)

Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Beutenbergstraße 11a, Jena, Germany.

Silvia Slesiona-Künzel (S)

Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Beutenbergstraße 11a, Jena, Germany.

Marc Swidergall (M)

The Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Ronny Martin (R)

Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.

Thomas Dandekar (T)

Department of Bioinformatics, Biocenter, Am Hubland, University of Würzburg, Würzburg, Germany.

Ilse D Jacobsen (ID)

Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Beutenbergstraße 11a, Jena, Germany. ilse.jacobsen@hki-jena.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH